(BMA) Banco Macro - Ratings and Ratios
Accounts, Cards, Loans, Deposits, Insurance
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.39% |
| Yield on Cost 5y | 19.87% |
| Yield CAGR 5y | 122.12% |
| Payout Consistency | 58.3% |
| Payout Ratio | - |
| Risk via 5d forecast | |
|---|---|
| Volatility | 58.8% |
| Value at Risk 5%th | 84.8% |
| Relative Tail Risk | -12.32% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.22 |
| Alpha | -27.77 |
| CAGR/Max DD | 1.38 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.577 |
| Beta | 1.335 |
| Beta Downside | 1.249 |
| Drawdowns 3y | |
|---|---|
| Max DD | 65.40% |
| Mean DD | 17.16% |
| Median DD | 13.68% |
Description: BMA Banco Macro November 07, 2025
Banco Macro S.A. (NYSE:BMA) is Argentina’s third-largest private-sector bank, offering a full suite of retail and corporate banking services-including deposits, consumer and mortgage loans, credit cards, cash-management, foreign-exchange, and digital banking platforms-through an extensive branch and ATM network headquartered in Buenos Aires.
Key recent performance indicators (Q3 2024): net profit of ≈ $312 million, a loan-portfolio expansion of ~ 9 % YoY, and a non-performing loan (NPL) ratio of 5.2 %-both above the Argentine banking average of ~ 4.8 % but improving from a 6.1 % peak in 2022. The bank’s cost-to-income ratio sits at 57 %, reflecting continued efficiency gains from its digital channel rollout.
Macro’s earnings are tightly linked to macro-economic drivers: Argentina’s inflation remains above 150 % YoY, eroding real deposit balances while boosting demand for short-term financing; the Central Bank’s policy rate (≈ 120 % as of Oct 2024) supports higher net interest margins but also raises funding costs. A modest devaluation of the peso against the USD (≈ 30 % since early 2024) has increased the bank’s foreign-currency exposure, which it partially hedges through its foreign-trade services.
Sector-wide, Argentine banks are navigating a “dual-track” environment-high-inflation, high-rate domestic lending alongside a constrained foreign-currency market. Consolidation pressure is rising as larger players seek scale to offset rising operational costs, making Macro’s diversified product mix and strong retail franchise a relative defensive advantage.
For a deeper quantitative assessment, you may find the ValueRay platform useful for benchmarking Macro’s valuation metrics against peers and historical baselines.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income (290.05b TTM) > 0 and > 6% of Revenue (6% = 305.66b TTM) |
| FCFTA -0.09 (>2.0%) and ΔFCFTA -20.09pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -173.4% (prev -61.83%; Δ -111.6pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.15 (>3.0%) and CFO -3115.59b <= Net Income 290.05b (YES >=105%, WARN >=100%) |
| Net Debt (-1696.37b) to EBITDA (407.74b) ratio: -4.16 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.27 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (63.9m) change vs 12m ago 0.06% (target <= -2.0% for YES) |
| Gross Margin 69.85% (prev 75.13%; Δ -5.28pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 29.28% (prev 52.34%; Δ -23.06pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.18 (EBITDA TTM 407.74b / Interest Expense TTM 1621.23b) >= 6 (WARN >= 3) |
Altman Z'' -2.47
| (A) -0.43 = (Total Current Assets 3190.04b - Total Current Liabilities 12025.10b) / Total Assets 20562.86b |
| (B) 0.01 = Retained Earnings (Balance) 176.20b / Total Assets 20562.86b |
| (C) 0.02 = EBIT TTM 287.45b / Avg Total Assets 17400.31b |
| (D) 0.20 = Book Value of Equity 3216.16b / Total Liabilities 15802.88b |
| Total Rating: -2.47 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 35.17
| 1. Piotroski 2.0pt |
| 2. FCF Yield -23.55% |
| 3. FCF Margin -34.89% |
| 4. Debt/Equity 0.31 |
| 5. Debt/Ebitda -4.16 |
| 6. ROIC - WACC (= -8.91)% |
| 7. RoE 6.53% |
| 8. Rev. Trend 75.18% |
| 9. EPS Trend 13.53% |
What is the price of BMA shares?
Over the past week, the price has changed by -0.53%, over one month by +7.14%, over three months by +103.57% and over the past year by -4.50%.
Is BMA a buy, sell or hold?
- Strong Buy: 2
- Buy: 2
- Hold: 3
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the BMA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 107.2 | 19.4% |
| Analysts Target Price | 107.2 | 19.4% |
| ValueRay Target Price | 153.3 | 70.7% |
BMA Fundamental Data Overview December 25, 2025
P/E Trailing = 36.5466
P/E Forward = 3.0979
P/S = 0.0024
P/B = 1.7616
P/EG = 0.9
Beta = 0.716
Revenue TTM = 5094.31b ARS
EBIT TTM = 287.45b ARS
EBITDA TTM = 407.74b ARS
Long Term Debt = 1414.05b ARS (from longTermDebt, last quarter)
Short Term Debt = 207.58b ARS (from shortTermDebt, last quarter)
Debt = 1493.67b ARS (from shortLongTermDebtTotal, last quarter)
Net Debt = -1696.37b ARS (from netDebt column, last quarter)
Enterprise Value = 7546.81b ARS (9243.17b + Debt 1493.67b - CCE 3190.04b)
Interest Coverage Ratio = 0.18 (Ebit TTM 287.45b / Interest Expense TTM 1621.23b)
FCF Yield = -23.55% (FCF TTM -1777.32b / Enterprise Value 7546.81b)
FCF Margin = -34.89% (FCF TTM -1777.32b / Revenue TTM 5094.31b)
Net Margin = 5.69% (Net Income TTM 290.05b / Revenue TTM 5094.31b)
Gross Margin = 69.85% ((Revenue TTM 5094.31b - Cost of Revenue TTM 1535.95b) / Revenue TTM)
Gross Margin QoQ = 52.38% (prev 64.87%)
Tobins Q-Ratio = 0.37 (Enterprise Value 7546.81b / Total Assets 20562.86b)
Interest Expense / Debt = 35.37% (Interest Expense 528.38b / Debt 1493.67b)
Taxrate = 13.05% (-4.96b / -38.03b)
NOPAT = 249.93b (EBIT 287.45b * (1 - 13.05%))
Current Ratio = 0.27 (Total Current Assets 3190.04b / Total Current Liabilities 12025.10b)
Debt / Equity = 0.31 (Debt 1493.67b / totalStockholderEquity, last quarter 4756.89b)
Debt / EBITDA = -4.16 (Net Debt -1696.37b / EBITDA 407.74b)
Debt / FCF = 0.95 (negative FCF - burning cash) (Net Debt -1696.37b / FCF TTM -1777.32b)
Total Stockholder Equity = 4440.33b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.41% (Net Income 290.05b / Total Assets 20562.86b)
RoE = 6.53% (Net Income TTM 290.05b / Total Stockholder Equity 4440.33b)
RoCE = 4.91% (EBIT 287.45b / Capital Employed (Equity 4440.33b + L.T.Debt 1414.05b))
RoIC = 4.78% (NOPAT 249.93b / Invested Capital 5225.17b)
WACC = 13.70% (E(9243.17b)/V(10736.84b) * Re(10.94%) + D(1493.67b)/V(10736.84b) * Rd(35.37%) * (1-Tc(0.13)))
Discount Rate = 10.94% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.02%
Fair Price DCF = unknown (Cash Flow -1777.32b)
EPS Correlation: 13.53 | EPS CAGR: -0.04% | SUE: -0.00 | # QB: 0
Revenue Correlation: 75.18 | Revenue CAGR: 88.59% | SUE: 0.18 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2977.30 | Chg30d=+37.258 | Revisions Net=+1 | Analysts=2
EPS next Year (2026-12-31): EPS=14149.30 | Chg30d=+77.120 | Revisions Net=+1 | Growth EPS=+31.7% | Growth Revenue=+13.3%
Additional Sources for BMA Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle